Tapewire

Nasdaq · USD

KNSA

Kiniksa Pharmaceuticals International, plc

Export transactions ↓
Tapewire entity
1954
SEC CIK
0001730430
Parsed reports
378

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202503
Jan 202601
Feb 202607
Mar 202605
Apr 2026012
May 202603
Jun 202600
Jul 202601
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 07, 2026 Filed Apr 8, 2026 20:39 UTC
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionClass A Ordinary Share 2,477 Not disclosed Not disclosed
Disclosure

SEC source: 0001857177-26-000004 · form4-04082026_080439.xml · nonDerivative · entry 2

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,506

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:38 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 3,932 $0.00 $0.00
Disclosure

SEC source: 0001464583-26-000004 · form4-04082026_080417.xml · derivative · entry 3

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Share · 3,932 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.

F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 7, 2022.

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:38 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Tax withholdingClass A Ordinary Share 1,666 $48.94 $81,534.04
Disclosure

SEC source: 0001464583-26-000004 · form4-04082026_080417.xml · nonDerivative · entry 2

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,043

Read SEC document
April 07, 2026 Filed Apr 8, 2026 20:38 UTC
Megna Michael RCHIEF ACCOUNTING OFFICER
Exercise / conversionClass A Ordinary Share 3,932 $1.00 $3,932.00
Disclosure

SEC source: 0001464583-26-000004 · form4-04082026_080417.xml · nonDerivative · entry 1

Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:43 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionShare Option · Derivative 7,278 $0.00 Strike: $10.36 $0.00
Disclosure

SEC source: 0001532218-26-000004 · form4-04082026_080403.xml · derivative · entry 7

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 431,904

Underlying: Class A Ordinary Share · 7,278 shares

Expires 2028-02-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:43 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
SaleClass A Ordinary Share 7,278 $50.01 $363,972.78
Disclosure

SEC source: 0001532218-26-000004 · form4-04082026_080403.xml · nonDerivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.005 and $50.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:43 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionClass A Ordinary Share 7,278 $10.36 $75,400.08
Disclosure

SEC source: 0001532218-26-000004 · form4-04082026_080403.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:39 UTC
Moat RossCHIEF OPERATING OFFICER
SaleClass A Ordinary Share 2,367 $48.58 $114,988.86
Disclosure

SEC source: 0001857177-26-000004 · form4-04082026_080439.xml · nonDerivative · entry 1

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,029

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on November 13, 2024.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:34 UTC Exercise / conversionShare Option · Derivative 6,901 $0.00 Strike: $14.33 $0.00
Disclosure

SEC source: 0001384243-26-000008 · form4-04082026_080443.xml · derivative · entry 3

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,336

Underlying: Class A Ordinary Shares · 6,901 shares

Expires 2031-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F3 · derivative.exercise_date: The option is fully vested and exercisable.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:34 UTC SaleClass A Ordinary Share 6,901 $50.00 $345,050.00
Disclosure

SEC source: 0001384243-26-000008 · form4-04082026_080443.xml · nonDerivative · entry 2

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,546

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.015. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Read SEC document
April 06, 2026 Filed Apr 8, 2026 20:34 UTC Exercise / conversionClass A Ordinary Share 6,901 $14.33 $98,891.33
Disclosure

SEC source: 0001384243-26-000008 · form4-04082026_080443.xml · nonDerivative · entry 1

Quart Barry D · CIK 0001384243 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,447

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,846 $0.00 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 8

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,536

Underlying: Class A Ordinary Share · 1,846 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,591 $0.00 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 7

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,182

Underlying: Class A Ordinary Share · 1,591 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 6

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Class A Ordinary Share · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F6 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

F6 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
GrantPerformance Share Unit · Derivative 15,600 $0.00 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 5

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,600

Underlying: Class A Ordinary Share · 15,600 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee

F5 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

F5 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
GrantRestricted Share Unit · Derivative 7,800 $0.00 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 4

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Class A Ordinary Share · 7,800 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F3 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F3 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
GrantShare Option · Derivative 31,150 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · derivative · entry 3

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,150

Underlying: Class A Ordinary Share · 31,150 shares

Expires 2036-03-31

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Tax withholdingClass A Ordinary Share 2,510 $48.13 $120,806.30
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · nonDerivative · entry 2

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,763

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:40 UTC
Ragosa MarkCHIEF FINANCIAL OFFICER
Exercise / conversionClass A Ordinary Share 5,187 Not disclosed Not disclosed
Disclosure

SEC source: 0001835458-26-000008 · form4-04032026_080402.xml · nonDerivative · entry 1

Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,273

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,457 $0.00 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 9

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,371

Underlying: Class A Ordinary Share · 2,457 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F9 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

F9 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,745 $0.00 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 8

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,490

Underlying: Class A Ordinary Share · 1,745 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,773 $0.00 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 7

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,772

Underlying: Class A Ordinary Share · 1,773 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
GrantPerformance Share Unit · Derivative 16,600 $0.00 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 6

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,600

Underlying: Class A Ordinary Share · 16,600 shares

Expires not disclosed

F5 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.

F6 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2028, unless such date falls on a non-business date, in which case the next business date shall apply.

F6 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2028, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
GrantRestricted Share Unit · Derivative 8,300 $0.00 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 5

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,300

Underlying: Class A Ordinary Share · 8,300 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F4 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F4 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
GrantShare Option · Derivative 33,200 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · derivative · entry 4

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,200

Underlying: Class A Ordinary Share · 33,200 shares

Expires 2036-03-31

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
Tax withholdingClass A Ordinary Share 1,756 $48.13 $84,516.28
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · nonDerivative · entry 3

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,250

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:41 UTC
Tessari EbenCHIEF STRATEGY OFFICER
Exercise / conversionClass A Ordinary Share 5,975 Not disclosed Not disclosed
Disclosure

SEC source: 0001867899-26-000002 · form4-04032026_080412.xml · nonDerivative · entry 2

Tessari Eben · CIK 0001867899 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,006

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionRestricted Share Unit · Derivative 8,609 $0.00 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 10

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,826

Underlying: Class A Ordinary Share · 8,609 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionRestricted Share Unit · Derivative 6,237 $0.00 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 9

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,475

Underlying: Class A Ordinary Share · 6,237 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionRestricted Share Unit · Derivative 6,481 $0.00 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 8

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,481

Underlying: Class A Ordinary Share · 6,481 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F6 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

F6 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
GrantPerformance Share Unit · Derivative 60,100 $0.00 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 7

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,100

Underlying: Class A Ordinary Share · 60,100 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.

F5 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

F5 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
GrantRestricted Share Unit · Derivative 30,050 $0.00 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 6

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,050

Underlying: Class A Ordinary Share · 30,050 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F3 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F3 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
GrantShare Option · Derivative 120,150 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · derivative · entry 5

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,150

Underlying: Class A Ordinary Share · 120,150 shares

Expires 2036-03-31

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Tax withholdingClass A Ordinary Share 10,313 $48.13 $496,364.69
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · nonDerivative · entry 2

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by The Patel Family Irrevocable Trust of 2025

Disclosed balance after: 71,014

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:39 UTC
Patel Sanj KDirector · CHAIRMAN & CEO
Exercise / conversionClass A Ordinary Share 21,327 Not disclosed Not disclosed
Disclosure

SEC source: 0001532218-26-000002 · form4-04032026_080457.xml · nonDerivative · entry 1

Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by The Patel Family Irrevocable Trust of 2025

Disclosed balance after: 81,327

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,457 $0.00 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 8

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,371

Underlying: Class A Ordinary Share · 2,457 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 7

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Class A Ordinary Share · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,624 $0.00 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 6

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,624

Underlying: Class A Ordinary Share · 1,624 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F6 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

F6 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
GrantPerformance Share Unit · Derivative 13,400 $0.00 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 5

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,400

Underlying: Class A Ordinary Share · 13,400 shares

Expires not disclosed

F4 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee

F5 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

F5 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
GrantRestricted Share Unit · Derivative 6,700 $0.00 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 4

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,700

Underlying: Class A Ordinary Share · 6,700 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

F3 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F3 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
GrantShare Option · Derivative 26,750 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · derivative · entry 3

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,750

Underlying: Class A Ordinary Share · 26,750 shares

Expires 2036-03-31

F2 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Tax withholdingClass A Ordinary Share 2,821 $48.13 $135,774.73
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · nonDerivative · entry 2

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,334

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:37 UTC
Paolini John F.CHIEF MEDICAL OFFICER
Exercise / conversionClass A Ordinary Share 5,831 Not disclosed Not disclosed
Disclosure

SEC source: 0001741533-26-000004 · form4-04032026_080425.xml · nonDerivative · entry 1

Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 2,457 $0.00 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 9

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,371

Underlying: Class A Ordinary Share · 2,457 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F9 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025.

F9 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,740 $0.00 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 8

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,481

Underlying: Class A Ordinary Share · 1,740 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F8 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2024.

F8 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2024.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
Exercise / conversionRestricted Share Unit · Derivative 1,611 $0.00 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 7

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,161

Underlying: Class A Ordinary Share · 1,611 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F7 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.

F7 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
GrantPerformance Share Unit · Derivative 18,500 $0.00 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 6

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,500

Underlying: Class A Ordinary Share · 18,500 shares

Expires not disclosed

F5 · derivative.exercise_price: Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee.

F6 · derivative.exercise_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

F6 · derivative.expiration_date: Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2029, unless such date falls on a non-business date, in which case the next business date shall apply.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
GrantRestricted Share Unit · Derivative 9,250 $0.00 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 5

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,250

Underlying: Class A Ordinary Share · 9,250 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.

F4 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

F4 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2026, and each yearly anniversary thereafter.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
GrantShare Option · Derivative 36,950 $0.00 Strike: $48.13 $0.00
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · derivative · entry 4

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,950

Underlying: Class A Ordinary Share · 36,950 shares

Expires 2036-03-31

F3 · derivative.exercise_date: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:35 UTC
Moat RossCHIEF OPERATING OFFICER
Tax withholdingClass A Ordinary Share 1,706 $48.13 $82,109.78
Disclosure

SEC source: 0001857177-26-000002 · form4-04032026_080450.xml · nonDerivative · entry 3

Moat Ross · CIK 0001857177 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,396

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.